EGFR and urinary bladder cancer: Interestingly, three gastrointestinal cancer types including pancreatic, gastric, and colorectal cancer, and bladder cancer were then identified as the most promising cancer types for cross-cancer prediction from EGFR-mutant NSCLC by our CONCORD analysis (Figure 5A).